Delivery systems at the near-atomic, or less than 1,000 nanometers typically 0.1nm to 100nm constitute nanotechnology. At this scale, chemical materials exhibit totally new characteristics and abilities to interact with the living organisms.

The use of nanotechnology to engineer delivery system that improve efficacy of API (Active Pharmaceutical Ingredients) is at the forefront of today’s medical science and the key to health improvement. They will reshape dramatically the way existing drugs are delivered.

The benefits of nanotech-based drug delivery systems will be spectacular: lowering drug toxicity, enhancing efficacy and reducing treatment costs.

AXIALYS intends to keep an innovative strategy, expanding and improving its delivery systems toolbox, to deliver unmatched benefits.